Status:
UNKNOWN
The Use of Continuous Wound Infusion Analgesia in Total Knee Arthroplasty
Lead Sponsor:
Capital Health, Canada
Conditions:
Total Knee Arthroplasty
Eligibility:
All Genders
18-69 years
Phase:
NA
Brief Summary
The main purpose of this study is to determine if there is improvement in pain and other patient outcomes when using a continuous wound analgesia system after total knee replacement, compared to usual...
Detailed Description
Continuous local wound infusion analgesia is a relatively new way of managing post-operative pain, whereby a local anesthetic is continuously infused into the surgical area. Some studies and users hav...
Eligibility Criteria
Inclusion
- Scheduled for TKA at the Royal Alexandra Hospital
- Patient of Dr. Arnett
- Deemed fit for continuous wound infusion (no allergies to Bupivacaine or related medications) by anesthesia
- Cognitively aware, and provides informed consent
- Elective (not trauma-related) surgery
- Able to read, speak and understand English
- Adult \< 70 years of age
- Intra-operative spinal anaesthesia
- Reside within metropolitan Edmonton, in a bungalow
- Have a caregiver at home
- ASA risk classification of 1 or 2
- Do not regularly use opioid medication pre-operatively
- Have preoperative knee range of motion \> 90 degrees
- Body Mass Index \< 40
- No known hepatic or liver insufficiency
Exclusion
- Deemed unfit for continuous wound infusion due to allergies
- Other exclusion criteria to be determined
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00724074
Last Update
July 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Alexandra Hospital
Edmonton, Alberta, Canada